Next-generation antibody-based therapeutics in cancer: antibody-drug conjugates bispecific antibodies across hematologic malignancies and solid tumors.
Antibody-based cancer treatments are advancing through systematic review of clinical data, offering clearer paths to personalized precision oncology.
This PubMed record reports: By distilling pivotal clinical data and highlighting unresolved questions, this review provides a roadmap for translating antibody‑based innovations into precision oncology. The finding is retained for rapid triage and requires downstream evidence review before clinical interpretation.
What the study was
- Study design
- Meta-analysis
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- Journal of hematology & oncology
Why it surfaced
Retained because its meta-analysis evidence is relevant to Precision oncology and genomic medicine; scoring is conservative for the available metadata.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.